An open-label study of escitalopram in body dysmorphic disorder.
about
Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directionsPharmacotherapy and psychotherapy for body dysmorphic disorderBody dysmorphic disorderDelusionality and response to open-label fluvoxamine in body dysmorphic disorderCan understanding the neurobiology of body dysmorphic disorder (BDD) inform treatment?Why do some promising brain-stimulation devices fail the next steps of clinical development?Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implicationsA prospective pilot study of levetiracetam for body dysmorphic disorder.Functional impairment in body dysmorphic disorder: a prospective, follow-up study.Age at onset and clinical correlates in body dysmorphic disorderA review of body dysmorphic disorder and its presentation in different clinical settings.Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments.A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorderSuicidality in Body Dysmorphic Disorder.Psychosomatic disturbances and cosmetic surgery.Psychopharmacological treatment of dermatological patients--when simply talking does not help.Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorderDelusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.Body dysmorphic disorder: treating an underrecognized disorder.Perceived ugliness: an update on treatment-relevant aspects of body dysmorphic disorder.Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.Pharmacotherapy for Body Dysmorphic Disorder.Mirtazapine Is Effective in Steroid Withdrawal Syndrome Related Depression: A Case Report.[Body dysmorphic disorder : Diagnostics and treatment in cosmetic dermatology].
P2860
Q22252300-53EAE101-DCDD-4E90-BBDB-A8762D27AE20Q24241607-2FE6282F-3A4E-47E7-A96F-90093D3255F6Q24635488-48BA6A9E-0128-4D41-A9FC-F0CBA1B4398FQ28360056-0BDA5B0B-9E8A-4F5E-8741-13248ED4100FQ30977757-0315F3A6-C9B4-4D1A-8C7B-1936E898D625Q33519672-5336AF8E-1F1D-42FF-B6CA-F6B5AE0BF51EQ33872639-8EA25400-B640-46C8-AF55-2540D122A698Q34139512-A2F51DB6-0674-4CE1-8ED5-D417B02AB0A6Q34235161-85B63E83-04C5-414D-A6B3-35EA247CF7C7Q34342844-9B25977C-2F02-4103-8F70-314CFC699619Q34395920-49E8E255-EBCD-417C-8870-C7FD1284482DQ34984955-2F5A549E-322B-4FE6-889B-B8477B0863D5Q36205142-61132832-6CB9-477C-ABE9-397D39C65627Q36614553-65716061-F624-4904-804B-313F69D0A68CQ36924407-71D92ED2-55F4-477C-B39E-00084025B141Q36945161-B77AA73F-9B6E-41FA-964D-080F9E6F397BQ37051214-87FC6107-3243-48AD-92DF-2ADDD4D2D4AEQ37102253-2D59AD1D-00E7-48E1-8943-A762D33D442BQ37104298-4E9108D5-126B-48F8-9728-B20805CA90FFQ37181077-48D70E83-0720-4B66-9AF8-0AD437B90BCFQ37276266-AF243663-857A-4703-946E-9B2106931ACBQ37871433-F317D915-529F-4C9D-AA4A-01F276F6440BQ41001091-58561648-4128-41C6-A582-AA7DB8ACDE3CQ41480222-A48D6C0B-C8C0-4393-B47C-118950473C69Q42324228-C1181221-3D0E-4C54-B03B-92FEF6F1EB94Q50093695-D6A98295-5FCE-4C54-BFD4-E671AD244177
P2860
An open-label study of escitalopram in body dysmorphic disorder.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An open-label study of escitalopram in body dysmorphic disorder.
@ast
An open-label study of escitalopram in body dysmorphic disorder.
@en
type
label
An open-label study of escitalopram in body dysmorphic disorder.
@ast
An open-label study of escitalopram in body dysmorphic disorder.
@en
prefLabel
An open-label study of escitalopram in body dysmorphic disorder.
@ast
An open-label study of escitalopram in body dysmorphic disorder.
@en
P2860
P1476
An open-label study of escitalopram in body dysmorphic disorder.
@en
P2093
Katharine A Phillips
P2860
P304
P356
10.1097/01.YIC.0000194378.65460.EF
P577
2006-05-01T00:00:00Z